Literature DB >> 24710923

Transient folate deprivation in combination with small-molecule compounds facilitates the generation of somatic cell-derived pluripotent stem cells in mice.

Wen-Tao Hu1, Qiu-Yue Yan2, Yu Fang1, Zhan-Dong Qiu1, Su-Ming Zhang3.   

Abstract

Induced pluripotent stem cells (iPSCs) can be propagated indefinitely, while maintaining the capacity to differentiate into all cell types in the body except for the extra-embryonic tissues. This iPSC technology not only represents a new way to use individual-specific stem cells for regenerative medicine but also constitutes a novel method to obtain large numbers of disease-specific cells for biomedical research. However, the low efficiency of reprogramming and genomic integration of oncogenes and viral vectors limit the potential application of iPSCs. Chemical-induced reprogramming offers a novel approach to generating iPSCs. In this study, a new combination of small-molecule compounds (SMs) (sodium butyrate, A-83-01, CHIR99021, Y-27632) under conditions of transient folate deprivation was used to generate iPSC. It was found that transient folate deprivation combined with SMs was sufficient to permit reprogramming from mouse embryonic fibroblasts (MEFs) in the presence of transcription factors, Oct4 and Klf4, within 25 days, replacing Sox2 and c-Myc, and accelerated the generation of mouse iPSCs. The resulting cell lines resembled mouse embryonic stem (ES) cells with respect to proliferation rate, morphology, pluripotency-associated markers and gene expressions. Deprivation of folic acid, combined with treating MEFs with SMs, can improve the inducing efficiency of iPSCs and reduce their carcinogenicity and the use of exogenous reprogramming factors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24710923     DOI: 10.1007/s11596-014-1249-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  23 in total

1.  Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors.

Authors:  Wenlin Li; Wei Wei; Saiyong Zhu; Jinliang Zhu; Yan Shi; Tongxiang Lin; Ergeng Hao; Alberto Hayek; Hongkui Deng; Sheng Ding
Journal:  Cell Stem Cell       Date:  2008-12-18       Impact factor: 24.633

Review 2.  Small molecules, big roles -- the chemical manipulation of stem cell fate and somatic cell reprogramming.

Authors:  Yu Zhang; Wenlin Li; Timothy Laurent; Sheng Ding
Journal:  J Cell Sci       Date:  2012-12-01       Impact factor: 5.285

3.  Progesterone receptor activation of extranuclear signaling pathways in regulating p53 expression in vascular endothelial cells.

Authors:  Sung-Po Hsu; Wen-Sen Lee
Journal:  Mol Endocrinol       Date:  2011-01-14

4.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

5.  MiR-138 promotes induced pluripotent stem cell generation through the regulation of the p53 signaling.

Authors:  Dan Ye; Guiying Wang; Yang Liu; Wenfei Huang; Minjuan Wu; Songcheng Zhu; Wenwen Jia; An-Mei Deng; Houqi Liu; Jiuhong Kang
Journal:  Stem Cells       Date:  2012-08       Impact factor: 6.277

6.  Folic acid inhibits endothelial cell proliferation through activating the cSrc/ERK 2/NF-κB/p53 pathway mediated by folic acid receptor.

Authors:  Shyr-Yi Lin; Woan-Ruoh Lee; Yi-Fan Su; Sung-Po Hsu; Hsu-Chen Lin; Pei-Yin Ho; Tien-Chi Hou; Yu-Pei Chou; Chun-Ting Kuo; Wen-Sen Lee
Journal:  Angiogenesis       Date:  2012-07-29       Impact factor: 9.596

Review 7.  iPSCs and small molecules: a reciprocal effort towards better approaches for drug discovery.

Authors:  Ru Zhang; Li-hong Zhang; Xin Xie
Journal:  Acta Pharmacol Sin       Date:  2013-04-22       Impact factor: 6.150

8.  miR-34 miRNAs provide a barrier for somatic cell reprogramming.

Authors:  Yong Jin Choi; Chao-Po Lin; Jaclyn J Ho; Xingyue He; Nobuhiro Okada; Pengcheng Bu; Yingchao Zhong; Sang Yong Kim; Margaux J Bennett; Caifu Chen; Arzu Ozturk; Geoffrey G Hicks; Greg J Hannon; Lin He
Journal:  Nat Cell Biol       Date:  2011-10-23       Impact factor: 28.824

Review 9.  Nuclear reprogramming strategy modulates differentiation potential of induced pluripotent stem cells.

Authors:  Almudena Martinez-Fernandez; Timothy J Nelson; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2011-01-05       Impact factor: 4.132

10.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.

Authors:  Danwei Huangfu; René Maehr; Wenjun Guo; Astrid Eijkelenboom; Melinda Snitow; Alice E Chen; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-06-22       Impact factor: 54.908

View more
  2 in total

1.  Derivation, Expansion, and Motor Neuron Differentiation of Human-Induced Pluripotent Stem Cells with Non-Integrating Episomal Vectors and a Defined Xenogeneic-free Culture System.

Authors:  Wentao Hu; Yongpei He; Yongjie Xiong; Hong Lu; Hong Chen; Limin Hou; Zhandong Qiu; Yu Fang; Suming Zhang
Journal:  Mol Neurobiol       Date:  2015-02-10       Impact factor: 5.590

Review 2.  Metabolic-Epigenetic Axis in Pluripotent State Transitions.

Authors:  Cristina D'Aniello; Federica Cermola; Eduardo J Patriarca; Gabriella Minchiotti
Journal:  Epigenomes       Date:  2019-07-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.